Oncolytics Biotech Ownership 2024 | Who Owns Oncolytics Biotech Now?
Institutional Ownership
1.74%
Insider Ownership
3.82%
Retail Ownership
94.44%
Institutional Holders
41.00
Oncolytics Biotech Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 0.26% | 0.02% | 198,400 | -3,052 | -1.51% | 196,416 | Jun 30, 2024 |
| SEEDS INVESTOR LLC | 0.25% | 0.10% | 189,941 | 189,941 | 100.00% | 188,042 | Jun 30, 2024 |
| MORGAN STANLEY | 0.18% | - | 138,521 | -209,792 | -60.23% | 137,136 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.11% | - | 83,598 | - | - | 82,762 | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.08% | 0.00% | 63,114 | 350 | 0.56% | 62,000 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.08% | - | 62,267 | 1,234 | 2.02% | 62,000 | Jun 30, 2024 |
| CIBC WORLD MARKET INC. | 0.08% | 0.00% | 57,835 | -315 | -0.54% | 57,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.06% | - | 41,942 | - | - | 41,522 | Jun 30, 2024 |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 0.05% | 0.00% | 40,000 | - | - | 39,600 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.05% | - | 37,425 | 105 | 0.28% | 38,851 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.04% | 0.00% | 27,442 | -24,447 | -47.11% | 27,000 | Jun 30, 2024 |
| BRAVE ASSET MANAGEMENT INC | 0.03% | 0.01% | 25,000 | - | - | 24,667 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.03% | - | 21,697 | 10,000 | 85.49% | 21,435 | Jun 30, 2024 |
| AUSDAL FINANCIAL PARTNERS, INC. | 0.03% | 0.00% | 21,000 | -5,000 | -19.23% | 20,790 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.03% | - | 20,509 | 2,500 | 13.88% | 20,304 | Jun 30, 2024 |
| HEADINVEST, LLC | 0.02% | 0.00% | 17,434 | 900 | 5.44% | 17,260 | Jun 30, 2024 |
| C2P CAPITAL ADVISORY GROUP, LLC D.B.A. PROSPERITY CAPITAL ADVISORS | 0.02% | 0.00% | 15,000 | - | - | 14,850 | Jun 30, 2024 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.02% | 0.00% | 13,294 | 10,000 | 303.58% | 13,110 | Jun 30, 2024 |
| BANQUE CANTONALE VAUDOISE | 0.02% | 0.00% | 11,900 | - | - | 12,000 | Jun 30, 2024 |
| KINGSVIEW WEALTH MANAGEMENT, LLC | 0.01% | 0.00% | 11,000 | - | - | 10,890 | Jun 30, 2024 |
Oncolytics Biotech's largest institutional shareholder is INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, holding 0.26% of the company's total share outstanding, currently valued at $196.42K. The top 10 institutional shareholders own together 1.21% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SEEDS INVESTOR LLC | 0.25% | 0.10% | 189,941 | 189,941 | 100.00% | 188,042 | Jun 30, 2024 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 0.26% | 0.02% | 198,400 | -3,052 | -1.51% | 196,416 | Jun 30, 2024 |
| BRAVE ASSET MANAGEMENT INC | 0.03% | 0.01% | 25,000 | - | - | 24,667 | Jun 30, 2024 |
| HEADINVEST, LLC | 0.02% | 0.00% | 17,434 | 900 | 5.44% | 17,260 | Jun 30, 2024 |
| AUSDAL FINANCIAL PARTNERS, INC. | 0.03% | 0.00% | 21,000 | -5,000 | -19.23% | 20,790 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.04% | 0.00% | 27,442 | -24,447 | -47.11% | 27,000 | Jun 30, 2024 |
| C2P CAPITAL ADVISORY GROUP, LLC D.B.A. PROSPERITY CAPITAL ADVISORS | 0.02% | 0.00% | 15,000 | - | - | 14,850 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.01% | 0.00% | 5,000 | 5,000 | 100.00% | 4,950 | Jun 30, 2024 |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 0.05% | 0.00% | 40,000 | - | - | 39,600 | Jun 30, 2024 |
| CEDAR MOUNTAIN ADVISORS, LLC | 0.01% | 0.00% | 5,651 | - | - | 5,594 | Jun 30, 2024 |
| PROFESSIONAL ADVISORY SERVICES INC | 0.01% | 0.00% | 10,000 | - | - | 10,000 | Jun 30, 2024 |
| PFG INVESTMENTS, LLC | 0.01% | 0.00% | 10,500 | - | - | 10,395 | Jun 30, 2024 |
| BANQUE CANTONALE VAUDOISE | 0.02% | 0.00% | 11,900 | - | - | 12,000 | Jun 30, 2024 |
| KINGSVIEW WEALTH MANAGEMENT, LLC | 0.01% | 0.00% | 11,000 | - | - | 10,890 | Jun 30, 2024 |
| CIBC WORLD MARKET INC. | 0.08% | 0.00% | 57,835 | -315 | -0.54% | 57,000 | Jun 30, 2024 |
| IFP ADVISORS, INC | 0.00% | 0.00% | 2,500 | - | - | 2,475 | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.08% | 0.00% | 63,114 | 350 | 0.56% | 62,000 | Jun 30, 2024 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.02% | 0.00% | 13,294 | 10,000 | 303.58% | 13,110 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.00% | 0.00% | 3,239 | 3,239 | 100.00% | 3,193 | Jun 30, 2024 |
| PACIFICA PARTNERS INC. | 0.00% | - | 100 | 100 | 100.00% | 101 | Jun 30, 2024 |
The largest Oncolytics Biotech shareholder by % of total assets is SEEDS INVESTOR LLC. The company owns 189.94K shares of Oncolytics Biotech (ONCY), representing 0.10% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SEEDS INVESTOR LLC | 0.25% | 0.10% | 189,941 | 189,941 | 100.00% | 188,042 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.03% | - | 21,697 | 10,000 | 85.49% | 21,435 | Jun 30, 2024 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.02% | 0.00% | 13,294 | 10,000 | 303.58% | 13,110 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.01% | 0.00% | 5,000 | 5,000 | 100.00% | 4,950 | Jun 30, 2024 |
| UBS GROUP AG | 0.01% | - | 5,603 | 4,439 | 381.36% | 5,547 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.00% | 0.00% | 3,239 | 3,239 | 100.00% | 3,193 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.03% | - | 20,509 | 2,500 | 13.88% | 20,304 | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | 0.00% | - | 2,000 | 2,000 | 100.00% | 2,060 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.00% | - | 1,900 | 1,900 | 100.00% | 1,881 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.08% | - | 62,267 | 1,234 | 2.02% | 62,000 | Jun 30, 2024 |
| HEADINVEST, LLC | 0.02% | 0.00% | 17,434 | 900 | 5.44% | 17,260 | Jun 30, 2024 |
| TD WATERHOUSE CANADA INC. | 0.00% | - | 662 | 662 | 100.00% | 1,032 | Jun 30, 2024 |
| TORONTO DOMINION BANK | 0.00% | - | 474 | 474 | 100.00% | 469 | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.08% | 0.00% | 63,114 | 350 | 0.56% | 62,000 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.05% | - | 37,425 | 105 | 0.28% | 38,851 | Jun 30, 2024 |
| PACIFICA PARTNERS INC. | 0.00% | - | 100 | 100 | 100.00% | 101 | Jun 30, 2024 |
| 0.00% | - | 56 | 56 | 100.00% | 55 | Jun 30, 2024 | |
| 1832 ASSET MANAGEMENT L.P. | - | - | 5 | - | - | 5 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.01% | - | 4,401 | - | - | 4,356 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.06% | - | 41,942 | - | - | 41,522 | Jun 30, 2024 |
As of Jun 30 2024, Oncolytics Biotech's largest institutional buyer is SEEDS INVESTOR LLC. The company purchased 189.94K stocks of ONCY, valued at $188.04K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 0.18% | - | 138,521 | -209,792 | -60.23% | 137,136 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -40,887 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.04% | 0.00% | 27,442 | -24,447 | -47.11% | 27,000 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -11,816 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -11,500 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -10,257 | -100.00% | - | Jun 30, 2024 |
| AUSDAL FINANCIAL PARTNERS, INC. | 0.03% | 0.00% | 21,000 | -5,000 | -19.23% | 20,790 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.01% | - | 8,497 | -4,842 | -36.30% | 8,411 | Jun 30, 2024 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 0.26% | 0.02% | 198,400 | -3,052 | -1.51% | 196,416 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 1,325 | -1,000 | -43.01% | 1,000 | Jun 30, 2024 |
| CIBC WORLD MARKET INC. | 0.08% | 0.00% | 57,835 | -315 | -0.54% | 57,000 | Jun 30, 2024 |
| BRAVE ASSET MANAGEMENT INC | 0.03% | 0.01% | 25,000 | - | - | 24,667 | Jun 30, 2024 |
| C2P CAPITAL ADVISORY GROUP, LLC D.B.A. PROSPERITY CAPITAL ADVISORS | 0.02% | 0.00% | 15,000 | - | - | 14,850 | Jun 30, 2024 |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 0.05% | 0.00% | 40,000 | - | - | 39,600 | Jun 30, 2024 |
| CEDAR MOUNTAIN ADVISORS, LLC | 0.01% | 0.00% | 5,651 | - | - | 5,594 | Jun 30, 2024 |
| PROFESSIONAL ADVISORY SERVICES INC | 0.01% | 0.00% | 10,000 | - | - | 10,000 | Jun 30, 2024 |
| PFG INVESTMENTS, LLC | 0.01% | 0.00% | 10,500 | - | - | 10,395 | Jun 30, 2024 |
| BANQUE CANTONALE VAUDOISE | 0.02% | 0.00% | 11,900 | - | - | 12,000 | Jun 30, 2024 |
| KINGSVIEW WEALTH MANAGEMENT, LLC | 0.01% | 0.00% | 11,000 | - | - | 10,890 | Jun 30, 2024 |
| IFP ADVISORS, INC | 0.00% | 0.00% | 2,500 | - | - | 2,475 | Jun 30, 2024 |
As of Jun 30 2024, Oncolytics Biotech's biggest institutional seller is MORGAN STANLEY. The company sold -0.21M shares of ONCY, valued at $137.14K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SEEDS INVESTOR LLC | 0.25% | 0.10% | 189,941 | 189,941 | 100.00% | 188,042 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.01% | 0.00% | 5,000 | 5,000 | 100.00% | 4,950 | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | 0.00% | - | 2,000 | 2,000 | 100.00% | 2,060 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.00% | - | 1,900 | 1,900 | 100.00% | 1,881 | Jun 30, 2024 |
| PACIFICA PARTNERS INC. | 0.00% | - | 100 | 100 | 100.00% | 101 | Jun 30, 2024 |
| 0.00% | - | 56 | 56 | 100.00% | 55 | Jun 30, 2024 |
Oncolytics Biotech's largest new institutional shareholder by number of shares is SEEDS INVESTOR LLC, purchased 189.94K shares, valued at $188.04K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | - | - | - | -40,887 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -11,816 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -11,500 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -10,257 | -100.00% | - | Jun 30, 2024 |
Oncolytics Biotech's largest sold out institutional shareholder by shares sold is MILLENNIUM MANAGEMENT LLC, sold -40.89K shares, valued at -, as of undefined.
Oncolytics Biotech Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| DFA INVESTMENT TRUST CO | 0.00% | 33,485 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 41,942 | - | - | Feb 29, 2024 |
Oncolytics Biotech's largest mutual fund holder by % of total assets is "DFA INVESTMENT TRUST CO", owning 33.48K shares, compromising 0.00% of its total assets.
Oncolytics Biotech Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 41 | 17.14% |
| 31 Mar, 24 | 35 | -18.60% |
| 31 Dec, 23 | 43 | 30.30% |
| 30 Sep, 23 | 33 | 10.00% |
| 30 Jun, 23 | 30 | -6.25% |
| 31 Mar, 23 | 32 | -8.57% |
| 31 Dec, 22 | 35 | 12.90% |
| 30 Sep, 22 | 31 | -16.22% |
| 30 Jun, 22 | 37 | 2.78% |
| 31 Mar, 22 | 36 | -2.70% |
| 31 Dec, 21 | 37 | 15.63% |
| 30 Sep, 21 | 32 | -15.79% |
| 30 Jun, 21 | 38 | 2.70% |
| 31 Mar, 21 | 37 | 23.33% |
| 31 Dec, 20 | 30 | -3.23% |
| 30 Sep, 20 | 31 | - |
| 30 Jun, 20 | 31 | 3.33% |
| 31 Mar, 20 | 30 | 25.00% |
| 31 Dec, 19 | 24 | 100.00% |
| 30 Sep, 19 | 12 | -20.00% |
| 30 Jun, 19 | 15 | -11.76% |
| 31 Mar, 19 | 17 | 21.43% |
| 31 Dec, 18 | 14 | -17.65% |
| 30 Sep, 18 | 17 | -5.56% |
| 30 Jun, 18 | 18 | - |
As of 30 Jun 24, 41 institutions are holding Oncolytics Biotech's shares, representing an increase of 17.14% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 1,309,286 | -7.29% |
| 31 Mar, 24 | 1,412,246 | -72.26% |
| 31 Dec, 23 | 5,090,222 | -18.12% |
| 30 Sep, 23 | 6,216,786 | 663.94% |
| 30 Jun, 23 | 813,781 | -28.53% |
| 31 Mar, 23 | 1,138,577 | 26.03% |
| 31 Dec, 22 | 903,449 | 26.13% |
| 30 Sep, 22 | 716,262 | -21.53% |
| 30 Jun, 22 | 912,743 | 29.71% |
| 31 Mar, 22 | 703,685 | -41.61% |
| 31 Dec, 21 | 1,205,091 | 15.02% |
| 30 Sep, 21 | 1,047,702 | -0.52% |
| 30 Jun, 21 | 1,053,138 | 0.04% |
| 31 Mar, 21 | 1,052,670 | -1.72% |
| 31 Dec, 20 | 1,071,088 | 35.06% |
| 30 Sep, 20 | 793,054 | -2.47% |
| 30 Jun, 20 | 813,137 | 38.21% |
| 31 Mar, 20 | 588,338 | 51.69% |
| 31 Dec, 19 | 387,855 | 0.87% |
| 30 Sep, 19 | 384,506 | -32.24% |
| 30 Jun, 19 | 567,457 | 204.42% |
| 31 Mar, 19 | 186,403 | 25.00% |
| 31 Dec, 18 | 149,117 | -16.40% |
| 30 Sep, 18 | 178,371 | -69.16% |
| 30 Jun, 18 | 578,446 | - |
Oncolytics Biotech (ONCY) has 1.31M shares outstanding as of 30 Jun 24, down -7.29% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 1.74% | 47.43% |
| 31 Mar, 24 | 1.92% | 3.60% |
| 31 Dec, 23 | 7.29% | 7.84% |
| 30 Sep, 23 | 9.64% | 565.98% |
| 30 Jun, 23 | 1.31% | 39.13% |
| 31 Mar, 23 | 1.83% | 36.41% |
| 31 Dec, 22 | 2.24% | 148.50% |
| 30 Sep, 22 | 1.23% | 49.02% |
| 30 Jun, 22 | 1.58% | 102.31% |
| 31 Mar, 22 | 1.24% | 25.87% |
| 31 Dec, 21 | 2.19% | 60.34% |
| 30 Sep, 21 | 1.91% | 50.72% |
| 30 Jun, 21 | 1.94% | 43.16% |
| 31 Mar, 21 | 2.12% | 32.16% |
| 31 Dec, 20 | 2.57% | 71.05% |
| 30 Sep, 20 | 1.90% | 45.09% |
| 30 Jun, 20 | 2.05% | 76.30% |
| 31 Mar, 20 | 1.64% | 53.44% |
| 31 Dec, 19 | 1.75% | 60.75% |
| 30 Sep, 19 | 1.70% | 21.48% |
| 30 Jun, 19 | 2.81% | 274.76% |
| 31 Mar, 19 | 1.01% | 116.71% |
| 31 Dec, 18 | 0.93% | 80.06% |
| 30 Sep, 18 | 1.08% | 7.65% |
| 30 Jun, 18 | 3.75% | - |
As of 30 Jun 24, Oncolytics Biotech is held by 1.74% institutional shareholders, representing a 47.43% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 18 | 28.57% |
| 31 Mar, 24 | 14 | -33.33% |
| 31 Dec, 23 | 21 | 31.25% |
| 30 Sep, 23 | 16 | 45.45% |
| 30 Jun, 23 | 11 | -31.25% |
| 31 Mar, 23 | 16 | -5.88% |
| 31 Dec, 22 | 17 | 54.55% |
| 30 Sep, 22 | 11 | - |
| 30 Jun, 22 | 11 | -26.67% |
| 31 Mar, 22 | 15 | -25.00% |
| 31 Dec, 21 | 20 | 100.00% |
| 30 Sep, 21 | 10 | -33.33% |
| 30 Jun, 21 | 15 | -37.50% |
| 31 Mar, 21 | 24 | 60.00% |
| 31 Dec, 20 | 15 | 25.00% |
| 30 Sep, 20 | 12 | -25.00% |
| 30 Jun, 20 | 16 | - |
| 31 Mar, 20 | 16 | -11.11% |
| 31 Dec, 19 | 18 | 157.14% |
| 30 Sep, 19 | 7 | - |
| 30 Jun, 19 | 7 | - |
| 31 Mar, 19 | 7 | 40.00% |
| 31 Dec, 18 | 5 | -50.00% |
| 30 Sep, 18 | 10 | -44.44% |
| 30 Jun, 18 | 18 | - |
18 institutional shareholders have increased their position in ONCY stock as of 30 Jun 24 compared to 14 in the previous quarter (a 28.57% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 8 | - |
| 31 Mar, 24 | 8 | -20.00% |
| 31 Dec, 23 | 10 | 100.00% |
| 30 Sep, 23 | 5 | -28.57% |
| 30 Jun, 23 | 7 | 75.00% |
| 31 Mar, 23 | 4 | -20.00% |
| 31 Dec, 22 | 5 | 150.00% |
| 30 Sep, 22 | 2 | -77.78% |
| 30 Jun, 22 | 9 | -10.00% |
| 31 Mar, 22 | 10 | 150.00% |
| 31 Dec, 21 | 4 | -50.00% |
| 30 Sep, 21 | 8 | - |
| 30 Jun, 21 | 8 | 100.00% |
| 31 Mar, 21 | 4 | - |
| 31 Dec, 20 | 4 | -42.86% |
| 30 Sep, 20 | 7 | 40.00% |
| 30 Jun, 20 | 5 | - |
| 31 Mar, 20 | 5 | 25.00% |
| 31 Dec, 19 | 4 | 300.00% |
| 30 Sep, 19 | 1 | -75.00% |
| 30 Jun, 19 | 4 | - |
| 31 Mar, 19 | 4 | - |
| 31 Dec, 18 | 4 | 33.33% |
| 30 Sep, 18 | 3 | - |
| 30 Jun, 18 | - | - |
8 institutional shareholders have reduced their position in ONCY stock as of 30 Jun 24 compared to 8 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 41 | 17.14% | 1,309,286 | -7.29% | 1.74% | 47.43% | 18 | 28.57% | 8 | - |
| 31 Mar, 24 | 35 | -18.60% | 1,412,246 | -72.26% | 1.92% | 3.60% | 14 | -33.33% | 8 | -20.00% |
| 31 Dec, 23 | 43 | 30.30% | 5,090,222 | -18.12% | 7.29% | 7.84% | 21 | 31.25% | 10 | 100.00% |
| 30 Sep, 23 | 33 | 10.00% | 6,216,786 | 663.94% | 9.64% | 565.98% | 16 | 45.45% | 5 | -28.57% |
| 30 Jun, 23 | 30 | -6.25% | 813,781 | -28.53% | 1.31% | 39.13% | 11 | -31.25% | 7 | 75.00% |
| 31 Mar, 23 | 32 | -8.57% | 1,138,577 | 26.03% | 1.83% | 36.41% | 16 | -5.88% | 4 | -20.00% |
| 31 Dec, 22 | 35 | 12.90% | 903,449 | 26.13% | 2.24% | 148.50% | 17 | 54.55% | 5 | 150.00% |
| 30 Sep, 22 | 31 | -16.22% | 716,262 | -21.53% | 1.23% | 49.02% | 11 | - | 2 | -77.78% |
| 30 Jun, 22 | 37 | 2.78% | 912,743 | 29.71% | 1.58% | 102.31% | 11 | -26.67% | 9 | -10.00% |
| 31 Mar, 22 | 36 | -2.70% | 703,685 | -41.61% | 1.24% | 25.87% | 15 | -25.00% | 10 | 150.00% |
| 31 Dec, 21 | 37 | 15.63% | 1,205,091 | 15.02% | 2.19% | 60.34% | 20 | 100.00% | 4 | -50.00% |
| 30 Sep, 21 | 32 | -15.79% | 1,047,702 | -0.52% | 1.91% | 50.72% | 10 | -33.33% | 8 | - |
| 30 Jun, 21 | 38 | 2.70% | 1,053,138 | 0.04% | 1.94% | 43.16% | 15 | -37.50% | 8 | 100.00% |
| 31 Mar, 21 | 37 | 23.33% | 1,052,670 | -1.72% | 2.12% | 32.16% | 24 | 60.00% | 4 | - |
| 31 Dec, 20 | 30 | -3.23% | 1,071,088 | 35.06% | 2.57% | 71.05% | 15 | 25.00% | 4 | -42.86% |
| 30 Sep, 20 | 31 | - | 793,054 | -2.47% | 1.90% | 45.09% | 12 | -25.00% | 7 | 40.00% |
| 30 Jun, 20 | 31 | 3.33% | 813,137 | 38.21% | 2.05% | 76.30% | 16 | - | 5 | - |
| 31 Mar, 20 | 30 | 25.00% | 588,338 | 51.69% | 1.64% | 53.44% | 16 | -11.11% | 5 | 25.00% |
| 31 Dec, 19 | 24 | 100.00% | 387,855 | 0.87% | 1.75% | 60.75% | 18 | 157.14% | 4 | 300.00% |
| 30 Sep, 19 | 12 | -20.00% | 384,506 | -32.24% | 1.70% | 21.48% | 7 | - | 1 | -75.00% |
| 30 Jun, 19 | 15 | -11.76% | 567,457 | 204.42% | 2.81% | 274.76% | 7 | - | 4 | - |
| 31 Mar, 19 | 17 | 21.43% | 186,403 | 25.00% | 1.01% | 116.71% | 7 | 40.00% | 4 | - |
| 31 Dec, 18 | 14 | -17.65% | 149,117 | -16.40% | 0.93% | 80.06% | 5 | -50.00% | 4 | 33.33% |
| 30 Sep, 18 | 17 | -5.56% | 178,371 | -69.16% | 1.08% | 7.65% | 10 | -44.44% | 3 | - |
| 30 Jun, 18 | 18 | - | 578,446 | - | 3.75% | - | 18 | - | - | - |
Oncolytics Biotech Peer Ownership
| Ticker | Company |
|---|---|
| XFOR | X4 Pharmaceuticals, Inc. |
| IKT | Inhibikase Therapeutics, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| SCPH | scPharmaceuticals Inc. |
| HOOK | HOOKIPA Pharma Inc. |
| CVAC | CureVac N.V. |
| MCRB | Seres Therapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| VIR | Vir Biotechnology, Inc. |
| KRYS | Krystal Biotech, Inc. |
| DMAC | DiaMedica Therapeutics Inc. |
| MIST | Milestone Pharmaceuticals Inc. |
| LIFE | aTyr Pharma, Inc. |
| GRTX | Galera Therapeutics, Inc. |
ONCY Ownership FAQ
Who Owns Oncolytics Biotech?
Oncolytics Biotech is owned by institutional shareholders (1.74%), insiders (3.82%), and public (94.44%). The largest institutional shareholder of Oncolytics Biotech is INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC (0.26% of total shares) and the top mutual fund owner is DFA INVESTMENT TRUST CO (0.00% of total shares).
Who are the major institutional shareholders of Oncolytics Biotech?
Oncolytics Biotech's major institutional shareholders are INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, SEEDS INVESTOR LLC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, and COMMONWEALTH EQUITY SERVICES, LLC. The top five shareholders own together 0.90% of the company's share outstanding.
How many Oncolytics Biotech shareholders are there?
As of Jun 2024, there are 41 institutional shareholders of Oncolytics Biotech.
What percentage of Oncolytics Biotech is owned by INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC?
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC owns 198.4K shares of Oncolytics Biotech, representing 0.26% of the company's total shares outstanding, valued at $196.42K (as of Jun 2024).
What percentage of Oncolytics Biotech is owned by SEEDS INVESTOR LLC?
As of Jun 2024, SEEDS INVESTOR LLC holds 189.94K shares of Oncolytics Biotech (ONCY), compromising 0.25% of the company, valued at $188.04K.
What percentage of Oncolytics Biotech is owned by MORGAN STANLEY?
MORGAN STANLEY is the third largest holder of Oncolytics Biotech. The company owns 138.52K of the company's shares outstanding (worth $137.14K).